ScienceDex / Researcher record
Marco Ruella
- University of Pennsylvania · Internal Medicine (NIH department code)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
- R01 Holder
- Top 10% Funded
- Early Career
NIH Funding · FY2025
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $501,149 | 1 | #30,563 |
| 2025 | $4,759,991 | 3 | #1,526 |
| 2026 | $3,273,076 | 5 | #5,457 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20241 record
- FY2025 · selected3 records
- FY20265 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12681981Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0003-4301-5811Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Internal Medicine
- Pathology
FY2025 award records by amount
NIH award records listing Marco Ruella as a PI. Multi-PI records show the full award amount for context.
- 1R01FD008168-01A1R01Co-investigatorCD5-deleted chimeric antigen receptor cells (Senza5 CART5) to enhance immunotherapy against T cell non-Hodgkin lymphoma (NHL): a first-in-human phase I clinical trialUniversity of Pennsylvania · Internal Medicine (NIH department code)$3.4Maward amount
- 1R01HL178849-01R01Co-investigatorSelective B Cell Depletion Using Engineered T Cells As A Curative Treatment For Acquired Thrombotic Thrombocytopenic PurpuraUniversity of Pennsylvania · Pathology (NIH department code)$810.9Kaward amount
- 5R37CA262362-04R37Contact PIMODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCERUniversity of Pennsylvania · Internal Medicine (NIH department code)$527.5Kaward amount
Award organization
Organizations that administered FY2025 awards listing Marco Ruella as a PI.
FY2025 award administered by University of Pennsylvania (PA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Pennsylvania
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025$5M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #1526
- 2025Entered Top 25% NationallyRanked #1526
- 2025Entered Top 10% NationallyRanked #1526
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Marco Ruella.